Dysfunction of TGF-β signaling in Alzheimer’s disease
Open Access
- 1 November 2006
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 116 (11) , 2855-2857
Abstract
Accumulation of β-amyloid peptide (Aβ) in the brain is believed to trigger a complex and poorly understood pathologic reaction that results in the development of Alzheimer’s disease (AD). Despite intensive study, there is no consensus as to how Aβ accumulation causes neurodegeneration in AD. In this issue of the JCI, Tesseur et al. report that the expression of TGF-β type II receptor (TβRII) by neurons is reduced very early in the course of AD and that reduced TGF-β signaling increased Aβ deposition and neurodegeneration in a mouse model of AD (see the related article beginning on page 3060). Intriguingly, reduced TGF-β signaling in neuroblastoma cells resulted in neuritic dystrophy and increased levels of secreted Aβ. Collectively, these data suggest that dysfunction of the TGF-β/TβRII signaling axis in the AD brain may accelerate Aβ deposition and neurodegeneration.Keywords
This publication has 18 references indexed in Scilit:
- Deficiency in neuronal TGF-β signaling promotes neurodegeneration and Alzheimer’s pathologyJournal of Clinical Investigation, 2006
- PirB Restricts Ocular-Dominance Plasticity in Visual CortexScience, 2006
- Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAENature Medicine, 2006
- TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSESAnnual Review of Immunology, 2006
- Distinct mechanisms of TGF- 1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesisJournal of Clinical Investigation, 2005
- Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic MiceNeuron, 2005
- Inflammation in Neurodegenerative Disease—A Double-Edged SwordNeuron, 2002
- Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivoNature, 2002
- TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic miceNature Medicine, 2001
- Inflammation and Alzheimer's diseaseNeurobiology of Aging, 2000